A study published in JAMA Network Open found that anticholinergic medicines commonly prescribed for overactive bladder may not increase dementia risk compared with beta-3 agonists, the newer class that has been considered safer for the brain.
Patients should not stop or change bladder medication without discussing it with their doctor.
Source: News-Medical















